This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/mesh/concept/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/wikipedia/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/pubchem-compound/
n18http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/kegg-drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/drugbank/
n20http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/chemspider/
n19http://linked.opendata.cz/resource/drugbank/drug/DB04599/identifier/chebi/

Statements

Subject Item
n2:DB04599
rdf:type
n3:Drug
n3:description
Compound with anti-depressive properties used as a mental performance enhancer.
n3:generalReferences
# Nakamura K, Kurasawa M: Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. Eur J Pharmacol. 2001 May 18;420(1):33-43. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11412837 # Lawrence JJ, Brenowitz S, Trussell LO: The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization. Mol Pharmacol. 2003 Aug;64(2):269-78. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/12869631
n3:group
experimental
n3:halfLife
1-2.5 hours
owl:sameAs
n18:DB04599 n20:DB04599
dcterms:title
Aniracetam
adms:identifier
n6:C13355 n7:D01883 n8:2111 n9:DB04599 n10:46506607 n11:4MP n12:2196 n13:Aniracetam n19:47943
n3:synonym
1-P-ANISOYL-2-PYRROLIDINONE
n14:hasConcept
n15:M0111076
n3:IUPAC-Name
n4:271B420D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4213-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4212-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B420F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4210-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4211-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B420B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B420C-363D-11E5-9242-09173F13E4C5 n4:271B4209-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B420A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4219-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B421A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4214-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4215-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4217-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4216-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4218-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
72432-10-1
n3:category
n3:Bioavailability
n4:271B421E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4220-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4221-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B421D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B421C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B421F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B420E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B421B-363D-11E5-9242-09173F13E4C5